Clozapine and risperidone treatment of Psychosis in Parkinson's Disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 3, 2000, Pages 364-369

  Ellis, T ^a   Cudkowicz, M E ^a   Sexton, P M ^a   Growdon, J H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MUSCLE RIGIDITY; NEUTROPENIA; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; URINE INCONTINENCE;

EID: 0033838729     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.3.364     Document Type: Article

References (35)

1. Clozapine for the treatment of psychosis in Parkinson's disease Chart review of 49 patients
2. Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease
3. Clozapine for the treatment-resistant schizophrenic. A double blind comparison with chlorpromazine
4. Clozapine and risperidone in chronic schizophrenia. Effects on symptoms, parkinsonian side effects and neuroendocrine response
5. Clozapine in the treatment of psychosis in Parkinson's disease
6. Clozapine is beneficial for psychosis in Parkinson's disease
7. Clozapine treatment of psychosis in Parkinson's disease: A report of five consecutive cases
8. Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine
9. Clozapine prevents recurrence of psychosis in Parkinson's disease
10. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease
11. Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis
12. Clozapine use in Parkinson's disease. A retrospective analysis of a large multicentered clinical experience
13. Clozapine in the treatment of tremor
14. Clozapine treatment of tremor in Parkinson's disease
15. Clozapine in the treatment of tremor in Parkinson's disease
16. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients. A multicentre double-blind comparative study
17. Risperidone: Clinical safety and efficacy in schizophrenia
18. Clinical review of risperidone
19. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
20. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease
21. Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
22. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes
23. Risperidone in Parkinson's disease
24. The Brief Psychiatric Rating Scale
25. The positive and negative syndrome scale and the Brief Psychiatric Rating Scale reliability: comparability and predictive validity
26. Clozapine treatment of Parkinsonism with psychosis
27. Portable system for quantifying motor abnormalities in Parkinson's disease IEEE
28. Parkinsonism: Onset, progression and mortality
29. Interrater reliability of the Blessed Dementia Scale
30. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
31. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
32. Dopaminomimetic psychosis in Parkinson's disease patients: Diagnosis and treatment